SCHEMBL4788136

SCHEMBL4788136

N#Cc1ccc2c(c1)CN(Cc1ccccc1)CCO2

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.51
DRD3 P35462 5/20 0.51
CYP2D6 P10635 2/20 0.48
ABCB1 P08183 2/20 0.45
PTGER2 P43116 4/20 0.44
HRH3 Q9Y5N1 1/20 0.43
CYP3A4 P08684 1/20 0.42
HIF1A Q16665 1/20 0.42
ADRA2A P08913 2/20 0.41
ADRA2B P18089 2/20 0.41
TMEM97 Q5BJF2 2/20 0.41
SIGMAR1 Q99720 2/20 0.41
DRD4 P21917 1/20 0.41
HRH1 P35367 1/20 0.41
HTR2B P41595 1/20 0.41
ADRA2C P18825 1/20 0.41
ACHE P22303 1/20 0.41
ALDH1A1 P00352 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3276408 0.81 CYP2D6 (0.51) DRD2DRD3CYP2D6PTGER2CYP3A4
SCHEMBL6436620 0.80 CYP2D6 (0.51) CYP2D6ADRA2AADRA2BTMEM97SIGMAR1
SCHEMBL19035635 0.79 DRD3 (0.60) DRD2DRD3HRH3ADRA2AADRA2B
SCHEMBL14023200 0.78 ALDH1A1 (0.53) CYP2D6PTGER2CYP3A4HIF1AACHE
SCHEMBL807310 0.78 CYP2D6 (0.48) CYP2D6PTGER2CYP3A4HIF1AADRA2A
SCHEMBL807032 0.78 CYP2D6 (0.53) DRD2DRD3CYP2D6PTGER2CYP3A4
SCHEMBL807306 0.77 CYP2D6 (0.53) DRD2CYP2D6PTGER2SIGMAR1ALDH1A1
SCHEMBL807305 0.77 SIGMAR1 (0.71) DRD2DRD3CYP2D6PTGER2ADRA2A
SCHEMBL807148 0.76 CYP2D6 (0.49) CYP2D6PTGER2CYP3A4HIF1AADRA2A
SCHEMBL807150 0.76 PTGER2 (0.59) CYP2D6PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012037105-A1 METHODS OF TREATING, AMELIORATING OR PREVENTING STRESS-INDUCED NEURONAL DISORDERS AND DISEASES THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2012-03-22 WO disclosed
WO-2012019071-A1 METHODS OF PREVENTING AND TREATING SARCOPENIA THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2012-02-09 WO disclosed
WO-2012019076-A1 COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CARDIAC ISCHEMIA/REPERFUSION INJURY THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2012-02-09 WO disclosed
WO-2008144483-A2 AGENTS FOR TREATING DISORDERS INVOLVING MODULATION OF RYANODINE RECEPTORS ARMGO PHARMA, INC. (US) 2008-11-27 WO disclosed
WO-2008144483-A2 AGENTS FOR TREATING DISORDERS INVOLVING MODULATION OF RYANODINE RECEPTORS ARMGO PHARMA, INC. (US) 2008-11-27 WO disclosed